Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Earplugs to reduce noise-related heart and metabolic risk

Official title: Impact of Personal Mitigation on Mechanisms Linking Transportation Noise Exposure to Cardiometabolic Disease

Run by Massachusetts General Hospital · NCT07148817 · Data updated 2026-11-12

This study will test whether wearing noise-canceling earplugs reduces stress-related brain activity and other heart-risk markers in adults with atherosclerosis or common cardiovascular risk factors who are bothered by transportation noise.

More Cardiometabolic Diseases trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment26 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Drugs / interventionsradiation
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedOctober 15, 2025
Main results expectedApril 1, 2028
Study endsJune 30, 2028
Registry record updatedNovember 3, 2025
Trial IDNCT07148817 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults who are annoyed by transportation noise or live in areas with average residential noise greater than 45 dBA and who have stable atherosclerosis or at least one typical cardiovascular risk factor are the intended participants.

Probably not a fit

Patients already using personal noise mitigation or those excluded for safety or confounding reasons (for example recent stroke, certain cardiovascular medications, pregnancy, claustrophobia, or active severe psychiatric/substance use disorders) are unlikely to receive benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional study compares nightly use of noise-canceling earplugs versus usual care in adults with stable atherosclerosis or at least one typical cardiovascular risk factor who report bothersome transportation noise or live in areas with high noise. Investigators will use FDG PET imaging to measure stress-associated neural activity (eg, amygdala-to-cortex metabolic patterns) and will collect autonomic, inflammatory, and vascular biomarkers before and after the intervention. Participants taking excluded cardiovascular medications or with neurologic/psychiatric contraindications will be screened out to ensure safety and interpretability. The goal is to determine whether simple personal noise mitigation lowers upstream stress signaling and downstream markers of cardiovascular risk.

Why it matters

Potential benefit: If successful, a low-cost intervention like earplugs could lower stress signaling and early markers of cardiovascular risk, potentially reducing long-term heart disease risk.

How similar studies have gone: Previous research has linked transportation noise to stress signaling and used FDG PET to measure stress-associated neural activity, but testing whether earplugs reduce those neural and cardiovascular markers is a relatively novel application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Describe feeling annoyed by transportation noise exposure or have high residential noise exposure (\>45 dBA average over 24 hours) using the United States Department of Transportation Map
* Known stable atherosclerosis or at least one typical risk factor (i.e., hypertension, diabetes, active smoking, or hyperlipidemia)
* Ability to understand and sign informed consent

Exclusion Criteria:

* History of stroke, brain surgery, or seizure
* Use of certain CVD medications (e.g., beta-blockers, high-intensity statins \[e.g., rosuvastatin 20/40 mg and atorvastatin 40/80 mg\], PCSK-9 inhibitors)
* Psychiatric or cardiovascular medication change within 3 months (i.e., stable regimen is allowed)
* Unstable blood pressure or cardiac arrhythmia
* Current use of personal noise mitigation techniques or involvement in stress management program
* Moderate/severe alcohol/substance use disorder
* Current mania/psychosis
* Weight \>300 lbs.
* Claustrophobia
* Pregnancy
* Metal implants
* Uncontrolled hyperglycemia (HgbA1c\>7.5%)
* Subjects who have had significant radiation exposure as part of research (\>2 nuclear tests, computed tomography images, or fluoroscopic procedures) during the preceding 12-months

Where it's running

  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.